Format

Send to

Choose Destination
Neuron. 2017 Mar 22;93(6):1296-1313. doi: 10.1016/j.neuron.2017.02.005.

New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

Author information

1
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: efeldman@umich.edu.
2
Department of Neurogenetics, Max Planck Institute for Experimental Medicine, 37075 G├Âttingen, Germany.
3
Department of Neurology and Danish Pain Research Center, Aarhus University, 8000 Aarhus C, Denmark.
4
Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford OX3 9DU, UK.

Abstract

Pre-diabetes and diabetes are a global epidemic, and the associated neuropathic complications create a substantial burden on both the afflicted patients and society as a whole. Given the enormity of the problem and the lack of effective therapies, there is a pressing need to understand the mechanisms underlying diabetic neuropathy (DN). In this review, we present the structural components of the peripheral nervous system that underlie its susceptibility to metabolic insults and then discuss the pathways that contribute to peripheral nerve injury in DN. We also discuss systems biology insights gleaned from the recent advances in biotechnology and bioinformatics, emerging ideas centered on the axon-Schwann cell relationship and associated bioenergetic crosstalk, and the rapid expansion of our knowledge of the mechanisms contributing to neuropathic pain in diabetes. These recent advances in our understanding of DN pathogenesis are paving the way for critical mechanism-based therapy development.

KEYWORDS:

Schwann cell; axon-glia crosstalk; bioenergetics; diabetic neuropathy; pain; peripheral nervous system; pre-diabetes; type 1 diabetes; type 2 diabetes

PMID:
28334605
PMCID:
PMC5400015
DOI:
10.1016/j.neuron.2017.02.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center